Explore
13D/13G Activist Filings
119,141 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | GLQ | Clough Global Equity Fund | Saba Capital Management, L.P. | 13D | 5.1% | 949K |
| Dec 9, 2025 | INCR | InterCure Ltd. | Alexander Rabinovich | 13D | 29.4% | 16.8M |
| Dec 9, 2025 | CHEC | CHENGHE ACQUISITION III CO | Picton Mahoney Asset Management | 13G | 7.7% | 1.0M |
| Dec 9, 2025 | CHECU | Chenghe Acquisition III Co. | Picton Mahoney Asset Management | 13G/A | 0.0% | 0 |
| Dec 9, 2025 | SINT | SINTX Technologies, Inc. | Gregg Richard Honigblum | 13G | 5.0% | 201K |
| Dec 9, 2025 | N/A | SEVEN HILLS REALTY TRUST | Tremont Realty Capital LLC | 13D/A | 20.3% | 4.6M |
| Dec 9, 2025 | ORLA | ORLA MINING LTD. | V. PREM WATSA | 13D/A | 20.3% | 78.1M |
| Dec 9, 2025 | BBW | Build-a-Bear Workshop, Inc. | Divisadero Street Capital Management, LP | 13G | 6.4% | 836K |
| Dec 9, 2025 | NEGG | Newegg Commerce, Inc. | Galkin Vladimir | 13D/A | 20.0% | 4.2M |
| Dec 9, 2025 | SYM | Symbotic Inc. | SoftBank Group Corp. | 13D/A | 37.7% | 45.4M |
| Dec 9, 2025 | OCUL | OCULAR THERAPEUTIX, INC | SUMMER ROAD LLC | 13G | 5.7% | 12.1M |
| Dec 8, 2025 | NCPL | Netcapital Inc. | Strategic EP, LLC | 13D/A | 6.9% | 339K |
| Dec 8, 2025 | FOA | FINANCE OF AMERICA COMPANIES INC. | BTO Urban Holdings L.L.C. | 13D/A | 27.1% | 2.8M |
| Dec 8, 2025 | EMPD | Empery Digital Inc. | Empery Asset Management, LP | 13D/A | 7.9% | 2.7M |
| Dec 8, 2025 | WULF | TERAWULF INC. | Citadel Securities GP LLC | 13G | 5.4% | 22.7M |
| Dec 8, 2025 | USAS | Americas Gold & Silver Corp | Sprott Eric | 13D/A | 16.3% | 50.1M |
| Dec 8, 2025 | BLUW | Blue Water Acquisition Corp. III | Harraden Circle Investments, LLC | 13G | 6.6% | 1.7M |
| Dec 8, 2025 | RVYL | RYVYL Inc. | RTB DIGITAL INC. | 13D/A | 16.6% | 7.2M |
| Dec 8, 2025 | BIXIU | Bitcoin Infrastructure Acquisition Corp Ltd | Tenor Capital Management Company, L.P. | 13G | 6.0% | 1.3M |
| Dec 8, 2025 | FEAM | 5E Advanced Materials, Inc. | Bluescape Energy Partners IV GP LLC | 13D/A | 34.6% | 8.1M |
| Dec 8, 2025 | CCRN | Cross Country Healthcare Inc | Magnetar Financial LLC | 13D/A | 5.5% | 1.8M |
| Dec 8, 2025 | SEI | Solaris Energy Infrastructure, Inc. | JANE STREET GROUP, LLC | 13G | 5.1% | 2.5M |
| Dec 8, 2025 | FEAM | 5E Advanced Materials, Inc. | Meridian Investments Corporation | 13D/A | 17.3% | 4.1M |
| Dec 8, 2025 | CBIO | Crescent Biopharma, Inc. | Fairmount Funds Management LLC | 13D/A | 18.5% | 5.6M |
| Dec 8, 2025 | LUNR | Intuitive Machines, Inc. | Kamal Seyed Ghaffarian | 13D/A | 25.6% | 39.7M |
| Dec 8, 2025 | GPACU | General Purpose Acquisition Corp. | Millennium Management LLC | 13G | 5.1% | 1.2M |
| Dec 8, 2025 | EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 13G/A | 10.0% | 8.3M |
| Dec 8, 2025 | VOD | VODAFONE GROUP PUBLIC LTD CO | Atlas 2022 Holdings Limited | 13D/A | 16.6% | 3.9B |
| Dec 8, 2025 | IMMR | IMMERSION CORP | Irrevocable Larson Family Investment Trust | 13D/A | 7.3% | 2.4M |
| Dec 8, 2025 | SRL | Scully Royalty Ltd. | Neil S. Subin | 13D/A | 13.0% | 2.0M |
| Dec 8, 2025 | N/A | PEARSON PLC | Cevian Capital II GP LTD | 13D/A | 14.2% | 90.2M |
| Dec 8, 2025 | SVRE | SaverOne 2014 Ltd. | Liu Yi Ming | 13G | 7.0% | 573.5M |
| Dec 8, 2025 | RLJ | RLJ Lodging Trust | He Zhengxu | 13G | 5.9% | 8.8M |
| Dec 8, 2025 | MBAV | M3-BRIGADE ACQUISITION V CORP. | Anson Funds Management LP | 13G | 9.9% | 2.9M |
| Dec 8, 2025 | CEPO | CANTOR EQUITY PARTNERS I, INC. | Anson Funds Management LP | 13G | 9.9% | 2.0M |
| Dec 8, 2025 | ILPT | Industrial Logistics Properties Trust | He Zhengxu | 13G/A | 4.9% | 3.3M |
| Dec 8, 2025 | MLP | MAUI LAND & PINEAPPLE COMPANY, INC. | VALUEWORKS LLC | 13G | 5.0% | 993K |
| Dec 8, 2025 | CARV | CARVER BANCORP INC | Detyga LLC | 13D | 5.3% | 272K |
| Dec 8, 2025 | TENX | TENAX THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 624K |
| Dec 8, 2025 | KTTA | PASITHEA THERAPEUTICS CORP. | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 10.2M |
| Dec 8, 2025 | PALI | PALISADE BIO, INC. | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 14.9M |
| Dec 8, 2025 | PTN | PALATIN TECHNOLOGIES INC | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 170K |
| Dec 8, 2025 | OVID | OVID THERAPEUTICS INC. | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 7.1M |
| Dec 8, 2025 | OCGN | OCUGEN, INC. | JANUS HENDERSON GROUP PLC | 13G | 6.0% | 20.0M |
| Dec 8, 2025 | LXEO | LEXEO THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 10.0% | 7.3M |
| Dec 8, 2025 | INO | INOVIO PHARMACEUTICALS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 10.0% | 6.7M |
| Dec 8, 2025 | IMUX | IMMUNIC, INC. | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 12.0M |
| Dec 8, 2025 | EQ | EQUILLIUM, INC. | JANUS HENDERSON GROUP PLC | 13G | 10.0% | 6.1M |
| Dec 8, 2025 | N/A | DBV TECHNOLOGIES S.A. | JANUS HENDERSON GROUP PLC | 13G | 9.5% | 20.5M |
| Dec 8, 2025 | BMEA | BIOMEA FUSION, INC. | JANUS HENDERSON GROUP PLC | 13G | 5.0% | 3.8M |